Psychedelic Prescriber Training
Clinical training for regulated prescribers on psychedelic-assisted care, covering screening, contraindications, medication management, dosing, and Canadian prescribing pathways. The course combines self-paced content with a short live component and is offered in psilocybin or MDMA tracks.
Provider
Details
Enrollment
Course Overview
Psychedelic Prescriber Training is a clinically focused masterclass for physicians and nurse practitioners working in regulated medical settings. It is designed to build practical understanding of prescribing pathways, risk mitigation, and the Canadian regulatory context for psychedelic-assisted psychotherapy. The curriculum covers neurobiology and neuropharmacology, dosing, evidence appraisal, drug interactions, contraindications, adverse events, patient populations, and special medical considerations. It also addresses TheraPsil roles, assessment and referral, SAP pathways, Section 56 considerations, documentation, and collaboration with care teams. The format is fully online and combines pre-readings, training videos, a live seminar, a live Q&A, and a short quiz. The listed time commitment is 8 hours total, and there are separate psilocybin and MDMA versions with different clinical examples and case framing.
Who is this for?
Primarily physicians, psychiatrists, and nurse practitioners who want clinically relevant training on psychedelic-assisted prescribing. Other clinicians and allied professionals may enroll for education.
Prerequisites
Built primarily for regulated medical prescribers (MD, NP).
About the Provider
TheraPsil is a Canadian grassroots nonprofit advancing compassionate, legal access to psilocybin-assisted psychotherapy through clinician training, patient advocacy, and legal reform, having trained over 700 healthcare professionals since 2019. The organization assists Canadians in navigating Health Canada's Special Access Program, supports patient-rights litigation in Federal Court, and operates the PsilWell community-funded clinical trial exploring psilocybin-assisted therapy for general wellbeing.
View Therapsil profileCourse Details
- Price$350
- FormatHybrid
- Lifecycle statusNo New Dates
- SkillsHarm ReductionPsychotherapyPsilocybin TherapyMDMA-Assisted TherapyEthicspsychedelic prescribingscreening and assessmentcontraindication reviewmedication managementrisk mitigationdosing protocolsevidence interpretationCanadian regulatory pathwaysSAP workflow awareness
- Categories
Related Courses
View all coursesAre Ketamine Clinics Paving the Way for Legal Psychedelic Therapy?
By Double Blind
An article examining whether ketamine clinics could serve as a model for future legal psychedelic therapy. It discusses current ketamine clinic practices, emerging regulation questions, and how clinics are preparing for MDMA and psilocybin services.
Certificate in Psychedelic-Assisted Therapies & Research | Ciisciis Logociis Logo
By CIIS
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Certificate in Psychedelic-Assisted Therapies and Research
By Fluence
A professional certificate program in psychedelic-assisted therapies and research offered by CIIS. It covers clinical and research foundations including pharmacology, research design, therapist competencies, and cultural and historical context.